National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Breast Cancer Screening (PDQ®)
Patient Version   Health Professional Version   Last Modified: 08/26/2008
Table 1. Harms of Screening Mammography

Harm  Study Design  Internal Validity  Consistency  Magnitude of Effects  External Validity 
Treatment of insignificant cancers (overdiagnosis, true positives) can result in breast deformity, lymphedema, thromboembolic events, new cancers, or chemotherapy-induced toxicities. Descriptive population-based, autopsy series and series of mammary reduction specimens Good Good Approximately 33% of breast cancers detected by screening mammograms represent overdiagnosis.[6] Good
Additional testing (false-positives) Descriptive population-based Good Good Estimated to occur in 50% of women screened annually for 10 years, 25% of whom will have biopsies.[7] Good
False sense of security, delay in cancer diagnosis (false-negatives) Descriptive population-based Good Good 6% to 46% of women with invasive cancer will have negative mammograms, especially if young, with dense breasts,[8,9] or with mucinous, lobular, or fast-growing cancers.[10] Good
Radiation-induced mutations can cause breast cancer, especially if exposed before age 30 years. Latency is more than 10 years, and the increased risk persists lifelong. Descriptive population-based Good Good Between 9.9 and 32 breast cancers per 10,000 women exposed to a cumulative dose of 1 Sv. Risk is higher for younger women.[11,12] Good

References

  1. Zahl PH, Strand BH, Maehlen J: Incidence of breast cancer in Norway and Sweden during introduction of nationwide screening: prospective cohort study. BMJ 328 (7445): 921-4, 2004.  [PUBMED Abstract]

  2. Elmore JG, Barton MB, Moceri VM, et al.: Ten-year risk of false positive screening mammograms and clinical breast examinations. N Engl J Med 338 (16): 1089-96, 1998.  [PUBMED Abstract]

  3. Rosenberg RD, Hunt WC, Williamson MR, et al.: Effects of age, breast density, ethnicity, and estrogen replacement therapy on screening mammographic sensitivity and cancer stage at diagnosis: review of 183,134 screening mammograms in Albuquerque, New Mexico. Radiology 209 (2): 511-8, 1998.  [PUBMED Abstract]

  4. Kerlikowske K, Grady D, Barclay J, et al.: Likelihood ratios for modern screening mammography. Risk of breast cancer based on age and mammographic interpretation. JAMA 276 (1): 39-43, 1996.  [PUBMED Abstract]

  5. Porter PL, El-Bastawissi AY, Mandelson MT, et al.: Breast tumor characteristics as predictors of mammographic detection: comparison of interval- and screen-detected cancers. J Natl Cancer Inst 91 (23): 2020-8, 1999.  [PUBMED Abstract]

  6. Ronckers CM, Erdmann CA, Land CE: Radiation and breast cancer: a review of current evidence. Breast Cancer Res 7 (1): 21-32, 2005.  [PUBMED Abstract]

  7. Goss PE, Sierra S: Current perspectives on radiation-induced breast cancer. J Clin Oncol 16 (1): 338-47, 1998.  [PUBMED Abstract]


A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov